Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 3;94(4):1317–1326. doi: 10.1038/s41390-023-02610-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 2 — a 17hydroxypregnanolone glucuronide in an infant treated with HC days 25–81 and receiving full oral feeds at day 44; b 17hydroxypregnanolone glucuronide in a control infant; c tigloylglycine, a metabolite of isoleucine, in a HC-treated infant days 24–52; d tigloylglycine in a control infant; e 6-sialyl-N-acetyllactosamine, an oligosaccharide, in a HC-treated infant days 14–48; f 6-sialyl-N-acetyllactosamine in a control infant. g Concentrations of erythronate and mevalonolactone in an infant receiving a 10-day course of HC; levels decrease on starting HC and increase 1.6- and 1.9-fold by off/on analysis on stopping HC. h Concentrations of erythronate and mevalonolactone remain lower until transitioning to oral feeds in an infant on HC days 25–81.